Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Alejandro Rodríguez-GarciaYolanda Macias-RodriguezJose M Gonzalez-Gonzalez

Published in: International ophthalmology (2017)

Lodoxamide 0.1% is an efficacious therapeutic alternative for the treatment of active and chronic SLK. This medication has proved to be safe and well tolerated.

Keyphrases

healthcare
emergency department
combination therapy
electronic health record